Olivia Candini

Head of Process Development, Cell & Gene Therapy at Evotec Modena

Speaker

Olivia Candini is the Senior Supervisor of Cell Therapy Process Development at Evotec Modena, where she actively advances iPSC-based therapeutics. A biotechnologist with a PhD in Experimental Medicine, Olivia has over 10 years of experience in academia and more than 8 years in the biotech industry. In 2016, she co-founded Rigenerand, contributing to the development of a cell and gene therapeutic candidate for pancreatic cancer, now entering clinical trials. Rigenerand was acquired by Evotec in 2022.